Literature DB >> 23698124

Class I histone deacetylase activity is required for proliferation of renal epithelial cells.

Jinhua Tang1, Yanli Yan, Ting C Zhao, George Bayliss, Haidong Yan, Shougang Zhuang.   

Abstract

The process of renal regeneration after acute kidney injury is thought to recapitulate renal development, and proliferation of renal proximal tubular cells (RPTCs) is a critical step in the regenerative response. Recent studies indicate that class I histone deacetylases (HDACs) are required for embryonic kidney gene expression, growth, and differentiation. The role and underlying mechanisms of class I HDAC activation in RPTC proliferation, however, remain unclear. In this study, we used cultured RPTCs to examine this issue since four class I HDAC isoforms (1, 2, 3, and 8) are abundantly expressed in this cell type. Blocking class I HDAC activity with a highly selective inhibitor, MS-275, induced global histone H3 hyperacetylation, reduced RPTC proliferation, and diminished expression of cyclin D1 and proliferating cell nuclear antigen. Silencing HDAC1, 3, or 8 with small interfering RNA resulted in similar biological effects. Activation of epidermal growth factor receptor (EGFR) and signal transducers and activators of transcription 3 (STAT3) was required for RPTC proliferation, and STAT3 functioned downstream of EGFR. Treatment with MS-275 or knockdown of HDAC1, 3, or 8 suppressed EGFR expression and phosphorylation, and silencing HDAC1 and 3 also reduced STAT3 phosphorylation. However, HDAC2 downregulation did not affect RPTC proliferation and phosphorylation of EGFR and STAT3. Collectively, these data reveal a critical role of class I HDACs in mediating proliferation of renal epithelial cells through activation of the EGFR/STAT3 signaling pathway.

Entities:  

Keywords:  class I histone deacetylases; epidermal growth factor receptor; proliferation; renal epithelial cells; signal transducers and activators of transcription 3

Mesh:

Substances:

Year:  2013        PMID: 23698124      PMCID: PMC3742866          DOI: 10.1152/ajprenal.00126.2013

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  53 in total

1.  Identification of novel isoform-selective inhibitors within class I histone deacetylases.

Authors:  Erding Hu; Edward Dul; Chiu-Mei Sung; Zunxuan Chen; Robert Kirkpatrick; Gui-Feng Zhang; Kyung Johanson; Ronggang Liu; Amparo Lago; Glenn Hofmann; Ricardo Macarron; Maite de los Frailes; Paloma Perez; John Krawiec; James Winkler; Michael Jaye
Journal:  J Pharmacol Exp Ther       Date:  2003-09-15       Impact factor: 4.030

2.  Targeted inactivation of EGF receptor inhibits renal collecting duct development and function.

Authors:  Zhao Zhang; Elena Pascuet; Pierre-Alain Hueber; Leelee Chu; Daniel G Bichet; Tang-Cheng Lee; David W Threadgill; Paul Goodyer
Journal:  J Am Soc Nephrol       Date:  2010-02-04       Impact factor: 10.121

3.  Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype.

Authors:  D W Threadgill; A A Dlugosz; L A Hansen; T Tennenbaum; U Lichti; D Yee; C LaMantia; T Mourton; K Herrup; R C Harris
Journal:  Science       Date:  1995-07-14       Impact factor: 47.728

4.  Transglutaminase-1 regulates renal epithelial cell proliferation through activation of Stat-3.

Authors:  Zhu Zhang; Jingping Xing; Li Ma; Rujun Gong; Y Eugene Chin; Shougang Zhuang
Journal:  J Biol Chem       Date:  2008-12-02       Impact factor: 5.157

Review 5.  Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure.

Authors:  Joseph V Bonventre
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

6.  Expression and function of P-glycoprotein in a mouse kidney cell line.

Authors:  S Ernest; E Bello-Reuss
Journal:  Am J Physiol       Date:  1995-08

7.  The class I HDAC inhibitor MGCD0103 induces cell cycle arrest and apoptosis in colon cancer initiating cells by upregulating Dickkopf-1 and non-canonical Wnt signaling.

Authors:  Shaheen Sikandar; Diana Dizon; Xiling Shen; Zuomei Li; Jeffery Besterman; Steven M Lipkin
Journal:  Oncotarget       Date:  2010-11

8.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Authors:  Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

9.  HDAC6 regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation in renal epithelial cells.

Authors:  Wei Liu; Lucy X Fan; Xia Zhou; William E Sweeney; Ellis D Avner; Xiaogang Li
Journal:  PLoS One       Date:  2012-11-13       Impact factor: 3.240

Review 10.  Role of epidermal growth factor receptor in acute and chronic kidney injury.

Authors:  Jinhua Tang; Na Liu; Shougang Zhuang
Journal:  Kidney Int       Date:  2013-01-16       Impact factor: 10.612

View more
  13 in total

1.  Dynamic changes in histone deacetylases following kidney ischemia-reperfusion injury are critical for promoting proximal tubule proliferation.

Authors:  Kelly A Hyndman; Malgorzata Kasztan; Luciano D Mendoza; Sureena Monteiro-Pai
Journal:  Am J Physiol Renal Physiol       Date:  2019-02-27

Review 2.  Epigenetics in acute kidney injury.

Authors:  Jinhua Tang; Shougang Zhuang
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-07       Impact factor: 2.894

3.  Class I HDAC activity is required for renal protection and regeneration after acute kidney injury.

Authors:  Jinhua Tang; Yanli Yan; Ting C Zhao; Rujun Gong; George Bayliss; Haidong Yan; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2014-05-07

Review 4.  Histone Deacetylases in Kidney Physiology and Acute Kidney Injury.

Authors:  Kelly A Hyndman
Journal:  Semin Nephrol       Date:  2020-03       Impact factor: 5.299

Review 5.  Application of Histone Deacetylase Inhibitors in Renal Interstitial Fibrosis.

Authors:  Ling Nie; Yong Liu; Bo Zhang; Jinghong Zhao
Journal:  Kidney Dis (Basel)       Date:  2020-03-26

Review 6.  Treatment of chronic kidney diseases with histone deacetylase inhibitors.

Authors:  Na Liu; Shougang Zhuang
Journal:  Front Physiol       Date:  2015-04-28       Impact factor: 4.566

7.  Anti-Double-Stranded DNA IgG Participates in Renal Fibrosis through Suppressing the Suppressor of Cytokine Signaling 1 Signals.

Authors:  Ping Wang; Jie Yang; Fang Tong; Zhaoyang Duan; Xingyin Liu; Linlin Xia; Ke Li; Yumin Xia
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

8.  Entinostat up-regulates the CAMP gene encoding LL-37 via activation of STAT3 and HIF-1α transcription factors.

Authors:  Erica Miraglia; Frank Nylén; Katarina Johansson; Elias Arnér; Marcus Cebula; Susan Farmand; Håkan Ottosson; Roger Strömberg; Gudmundur H Gudmundsson; Birgitta Agerberth; Peter Bergman
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

9.  Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease.

Authors:  Hong Sang Choi; Ji Hong Song; In Jin Kim; Soo Yeon Joo; Gwang Hyeon Eom; Inkyeom Kim; Hyunju Cha; Joong Myung Cho; Seong Kwon Ma; Soo Wan Kim; Eun Hui Bae
Journal:  Sci Rep       Date:  2018-08-01       Impact factor: 4.379

Review 10.  The Role and Mechanism of Histone Deacetylases in Acute Kidney Injury.

Authors:  Xun Zhou; Hui Chen; Yingfeng Shi; Xiaoyan Ma; Shougang Zhuang; Na Liu
Journal:  Front Pharmacol       Date:  2021-06-16       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.